ArticleInternational journal of cancer2023

Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Vicky C Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.